BGMS Company Profile and Key Details

Bio Green Med Solution, Inc. has 6.62 million shares outstanding. The public float is 5.31 million shares, elevated short interest at 1.58% of float. This equals 66.63 thousand shares. The short ratio is 0.76 days. Institutional investors hold 3.27% of the float. Insiders own 45.2%. FITTERS Diversified Berhad holds 279.25 thousand shares, Kua Khai Loon has 0.00 shares and Ong Yee Lung has 0.00 shares.

Bio Green Med Solution, Inc. (NASDAQ:BGMS) closed at $0.87 USD, gaining $0.03 (3.18%) from the previous close of $0.85. The stock is currently mid-range between its 52-week high and low $0.57 and $6.70. With a market capitalization of about $4.81 million, Bio Green Med Solution, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.39). Key stats such as the average daily volume over the past year has been around 76.12 thousand shares, volume is running light vs its 52-week average. Headquartered in Kuala Lumpur, LF, Bio Green Med Solution, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Sing Ee Wong, the company employs approximately 12 people and listed since September 12, 2025. Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries.

Bio Green Med Solution, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.35. This means the shares are trading below this model’s fair value.

BGMS has shown mixed momentum, gaining 12.54% over the past week and -63.79% over the past quarter, though year-to-date performance is down -1.15%. Short-term trend indicators are bullishly aligned (SMA20 -2.32%, SMA50 -19.45%, SMA200 -84.0%). The stock’s 14-day RSI is 41.58 (neutral), while the ATR of 0.1 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.0% below its high and over 35.79% above its low. Average 10-day trading volume of 16.41 thousand shares is below the 3-month average of 73.87 thousand, indicating normal recent market interest.

Bio Green Med Solution, Inc. generated EPS of -$84.87 over the past year. Five-year average earnings growth is 57.31%. Bio Green Med Solution, Inc. earnings surprise history is a mixed track record. The quarter that ended March 30, 2026, missed forecasts by -96.93%. The prior quarter beat by -98.18%. Over the last six quarters, Apple has recorded several small beats. These include -98.18% in November 13, 2025.

Our AI price prediction model suggests that Bio Green Med Solution, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.82%, with price expected at $0.83 by September 25, 2026, within a range of $0.78 to $0.87 3-Month Outlook: Projected fall of -0.23%, reaching $0.87 by December 10, 2026, with a range of $0.74 to $0.96. 1-Year Outlook: Projected gain of 163.76%, with price at $2.30 by September 10, 2027, within a range of $0.14 to $2.21.

Bio Green Med Solution, Inc. (NASDAQ:BGMS) shares are flat -1.15% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Bio Green Med Solution, Inc. trading at a premium to the broader market with a P/E of -0.24. Our AI forecast model points to short-term weakness (-4.82% over two weeks), a medium-term fall (-0.23% over three months), and a longer-term gain (163.76% over one year), with expected trading ranges indicating moderate volatility.

Bio Green Med Solution, Inc. trades at a P/E ratio of -0.24, slightly below the S&P 500 average, with a price-to-sales ratio of 2.59 and a price-to-book ratio of 0.68 suggesting the stock is closer to book value. The P/FCF stands at -4.39, also below market averages.